Meomind

When Meomind was founded in January 2022, they knew data would play a huge role. Their data is segmented into product, marketing, and clinical, and they leverage it to assess metrics like potential clinical impact, listening frequency, and user satisfaction. The small data team knew their qualitative data would grow with the company, so they needed a scalable, easy-to-use solution to get everything in one place.